top of page

Cigna and Aetna sign pay-for-performance deal with Novartis for Entresto drug

US-based health insurance companies Cigna and Aetna have signed contracts with Swiss drug manufacturer Novartis for a performance-based price for the company’s new heart drug Entresto. The pay-for-performance agreements are expected to set pricing on certain drugs based on how they work for certain patients.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page